CN113322348A - 一种高灵敏新型冠状病毒2019-nCoV核酸检测试剂盒及使用方法 - Google Patents
一种高灵敏新型冠状病毒2019-nCoV核酸检测试剂盒及使用方法 Download PDFInfo
- Publication number
- CN113322348A CN113322348A CN202110329273.0A CN202110329273A CN113322348A CN 113322348 A CN113322348 A CN 113322348A CN 202110329273 A CN202110329273 A CN 202110329273A CN 113322348 A CN113322348 A CN 113322348A
- Authority
- CN
- China
- Prior art keywords
- gene
- probe
- nucleic acid
- orf1ab
- internal standard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 117
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 58
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 58
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 42
- 241001678559 COVID-19 virus Species 0.000 title claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 148
- 239000000523 sample Substances 0.000 claims abstract description 115
- 230000003321 amplification Effects 0.000 claims abstract description 19
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 239000000243 solution Substances 0.000 claims description 35
- 238000011144 upstream manufacturing Methods 0.000 claims description 20
- 239000013642 negative control Substances 0.000 claims description 18
- 239000013641 positive control Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 7
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 7
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 7
- 238000003757 reverse transcription PCR Methods 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 5
- 241001112090 Pseudovirus Species 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 238000012340 reverse transcriptase PCR Methods 0.000 claims description 2
- 102100034343 Integrase Human genes 0.000 claims 2
- 210000005260 human cell Anatomy 0.000 claims 1
- 241000711573 Coronaviridae Species 0.000 abstract description 57
- 238000000605 extraction Methods 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 102000004167 Ribonuclease P Human genes 0.000 abstract description 4
- 108090000621 Ribonuclease P Proteins 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 20
- 241000700605 Viruses Species 0.000 description 13
- 244000309467 Human Coronavirus Species 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000007850 fluorescent dye Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 102100034349 Integrase Human genes 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 230000004544 DNA amplification Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 102100031673 Corneodesmosin Human genes 0.000 description 2
- 101710139375 Corneodesmosin Proteins 0.000 description 2
- 241000712431 Influenza A virus Species 0.000 description 2
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 2
- 241001292005 Nidovirales Species 0.000 description 2
- 108091092724 Noncoding DNA Proteins 0.000 description 2
- 101710141454 Nucleoprotein Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 241000725643 Respiratory syncytial virus Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000007847 digital PCR Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 241000538562 Banjos Species 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108700002099 Coronavirus Nucleocapsid Proteins Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
- 241000711467 Human coronavirus 229E Species 0.000 description 1
- 241001109669 Human coronavirus HKU1 Species 0.000 description 1
- 241000482741 Human coronavirus NL63 Species 0.000 description 1
- 241001428935 Human coronavirus OC43 Species 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 102100024407 Jouberin Human genes 0.000 description 1
- 101710145006 Lysis protein Proteins 0.000 description 1
- 101710085938 Matrix protein Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 101710127721 Membrane protein Proteins 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
- 206010028740 Nasal dryness Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 101150001779 ORF1a gene Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 108091036407 Polyadenylation Proteins 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 101710198474 Spike protein Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- PPZMYIBUHIPZOS-UHFFFAOYSA-N histamine dihydrochloride Chemical compound Cl.Cl.NCCC1=CN=CN1 PPZMYIBUHIPZOS-UHFFFAOYSA-N 0.000 description 1
- 229960000645 histamine hydrochloride Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960001664 mometasone Drugs 0.000 description 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
- 229960003128 mupirocin Drugs 0.000 description 1
- 229930187697 mupirocin Natural products 0.000 description 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
- 229960003752 oseltamivir Drugs 0.000 description 1
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- XRQDFNLINLXZLB-CKIKVBCHSA-N peramivir Chemical compound CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(O)=O)C[C@H]1NC(N)=N XRQDFNLINLXZLB-CKIKVBCHSA-N 0.000 description 1
- 229960001084 peramivir Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229960001028 zanamivir Drugs 0.000 description 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110329273.0A CN113322348A (zh) | 2021-03-27 | 2021-03-27 | 一种高灵敏新型冠状病毒2019-nCoV核酸检测试剂盒及使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110329273.0A CN113322348A (zh) | 2021-03-27 | 2021-03-27 | 一种高灵敏新型冠状病毒2019-nCoV核酸检测试剂盒及使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113322348A true CN113322348A (zh) | 2021-08-31 |
Family
ID=77414606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110329273.0A Pending CN113322348A (zh) | 2021-03-27 | 2021-03-27 | 一种高灵敏新型冠状病毒2019-nCoV核酸检测试剂盒及使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113322348A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111676278A (zh) * | 2020-04-21 | 2020-09-18 | 中国贵州茅台酒厂(集团)有限责任公司职工医院 | 一种检测新型冠状病毒n基因的引物和探针及其试剂盒和方法 |
CN111690772A (zh) * | 2020-06-15 | 2020-09-22 | 桂林优利特医疗电子有限公司 | 一种新冠病毒核酸检测试剂盒、制备方法及应用 |
CN113801966A (zh) * | 2021-11-03 | 2021-12-17 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 一种检测新型冠状病毒亚基因的荧光定量pcr方法及试剂盒 |
CN113862400A (zh) * | 2021-12-01 | 2021-12-31 | 上海思路迪医学检验所有限公司 | 检测新冠病毒和肺炎病原菌的引物探针组合及检测试剂盒 |
CN114317822A (zh) * | 2021-12-28 | 2022-04-12 | 山西大学 | 一种检测新冠病毒核酸的多重荧光定量pcr方法 |
CN116426543A (zh) * | 2021-12-30 | 2023-07-14 | 珠海丽凡达生物技术有限公司 | 一种新型冠状病毒疫苗及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110982942A (zh) * | 2020-03-02 | 2020-04-10 | 圣湘生物科技股份有限公司 | 检测冠状病毒并分型的组合物、试剂盒、方法及其用途 |
CN111705161A (zh) * | 2020-04-28 | 2020-09-25 | 安徽同科生物科技有限公司 | 一种新型冠状病毒2019-nCoV核酸检测引物组合物及试剂盒 |
CN111733286A (zh) * | 2020-06-12 | 2020-10-02 | 北京航空航天大学 | 新型冠状病毒环介导等温扩增检测方法及试剂盒 |
CN112029831A (zh) * | 2020-08-15 | 2020-12-04 | 天筛(上海)科技有限公司 | 一种极低载量病原微生物的超灵敏定量pcr检测技术 |
CN112458210A (zh) * | 2020-12-09 | 2021-03-09 | 上海伯杰医疗科技有限公司 | 一种用于检测新冠病毒的基因保守序列、引物探针组合、试剂盒及应用 |
-
2021
- 2021-03-27 CN CN202110329273.0A patent/CN113322348A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110982942A (zh) * | 2020-03-02 | 2020-04-10 | 圣湘生物科技股份有限公司 | 检测冠状病毒并分型的组合物、试剂盒、方法及其用途 |
CN111705161A (zh) * | 2020-04-28 | 2020-09-25 | 安徽同科生物科技有限公司 | 一种新型冠状病毒2019-nCoV核酸检测引物组合物及试剂盒 |
CN111733286A (zh) * | 2020-06-12 | 2020-10-02 | 北京航空航天大学 | 新型冠状病毒环介导等温扩增检测方法及试剂盒 |
CN112029831A (zh) * | 2020-08-15 | 2020-12-04 | 天筛(上海)科技有限公司 | 一种极低载量病原微生物的超灵敏定量pcr检测技术 |
CN112458210A (zh) * | 2020-12-09 | 2021-03-09 | 上海伯杰医疗科技有限公司 | 一种用于检测新冠病毒的基因保守序列、引物探针组合、试剂盒及应用 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111676278A (zh) * | 2020-04-21 | 2020-09-18 | 中国贵州茅台酒厂(集团)有限责任公司职工医院 | 一种检测新型冠状病毒n基因的引物和探针及其试剂盒和方法 |
CN111690772A (zh) * | 2020-06-15 | 2020-09-22 | 桂林优利特医疗电子有限公司 | 一种新冠病毒核酸检测试剂盒、制备方法及应用 |
CN113801966A (zh) * | 2021-11-03 | 2021-12-17 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 一种检测新型冠状病毒亚基因的荧光定量pcr方法及试剂盒 |
CN113862400A (zh) * | 2021-12-01 | 2021-12-31 | 上海思路迪医学检验所有限公司 | 检测新冠病毒和肺炎病原菌的引物探针组合及检测试剂盒 |
CN113862400B (zh) * | 2021-12-01 | 2022-03-08 | 上海思路迪医学检验所有限公司 | 检测新冠病毒和肺炎病原菌的引物探针组合及检测试剂盒 |
CN114317822A (zh) * | 2021-12-28 | 2022-04-12 | 山西大学 | 一种检测新冠病毒核酸的多重荧光定量pcr方法 |
CN116426543A (zh) * | 2021-12-30 | 2023-07-14 | 珠海丽凡达生物技术有限公司 | 一种新型冠状病毒疫苗及其制备方法 |
CN116426543B (zh) * | 2021-12-30 | 2024-03-22 | 珠海丽凡达生物技术有限公司 | 一种新型冠状病毒疫苗及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113322348A (zh) | 一种高灵敏新型冠状病毒2019-nCoV核酸检测试剂盒及使用方法 | |
WO2021174674A1 (zh) | 检测冠状病毒并分型的组合物、试剂盒及方法 | |
CN111321251B (zh) | 检测引起呼吸道感染的病原体并分型的组合物、试剂盒、方法及用途 | |
EP4012050A1 (en) | Composition, kit and method for detecting and typing viruses causing respiratory tract infection and application of composition, kit and method | |
WO2022095723A1 (zh) | 用于检测SARS-CoV-2的试剂盒及方法 | |
EP4101935A1 (en) | Nucleic acid detection kit for novel coronavirus 2019-ncov | |
CN113943830A (zh) | 一种用于同时检测猫细小病毒、猫疱疹病毒1型和猫杯状病毒的引物探针组及试剂盒 | |
CN105543414B (zh) | 一种呼吸道合胞病毒a/b亚型多重荧光定量pcr检测引物组和探针组及其试剂盒和制备方法 | |
WO2023087868A1 (en) | Compositions, kits, methods for detecting and identifying pathogens that cause respiratory tract infections and use thereof | |
CN113005226A (zh) | 检测SARS-CoV-2的寡核苷酸和试剂盒 | |
CN105886663B (zh) | 一种锁核酸增敏的猪伪狂犬病毒野毒株荧光定量pcr的检测试剂盒 | |
CN110724764A (zh) | 人冠状病毒和呼吸道合胞病毒荧光定量pcr检测方法及其应用 | |
CN112410470A (zh) | 新型冠状病毒和甲型、乙型流感病毒核酸快速检测试剂盒 | |
CN113564280A (zh) | 一种用于检测禽腺病毒i群12个血清型的raa引物及其检测方法 | |
CN113005228A (zh) | 一种同步检测多项呼吸道病原体的检测试剂盒及其检测方法 | |
CN103146846A (zh) | 一种基于单一标准品的四色荧光定量pcr方法和试剂盒 | |
CN111808990A (zh) | 2019-nCoV核酸检测试剂盒 | |
CN114958975A (zh) | 重组酶介导的等温核酸扩增组合产品 | |
CN113637795A (zh) | 一种甲型/乙型流感病毒、新型冠状病毒检测方法与试剂盒 | |
CN116790815A (zh) | 检测偏肺病毒的试剂盒 | |
WO2023109031A1 (zh) | 一种呼吸道病原体检测试剂盒及其制备方法与应用 | |
CN113817870B (zh) | 同时检测七种呼吸道相关病毒的引物组合物及其应用 | |
CN110724763A (zh) | 人腺病毒和博卡病毒荧光定量pcr检测方法及其应用 | |
CN115612753A (zh) | 一种阿留申、肠炎、犬瘟热病检测的方法 | |
CN114438266A (zh) | 一种检测多种常见鸭源病毒的试剂盒及检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Shengqi Inventor after: Liu Qiqi Inventor after: Liu Liyan Inventor after: Zhang Ying Inventor after: Hou Guangzheng Inventor before: Wang Shengqi Inventor before: Liu Qi Inventor before: Liu Liyan Inventor before: Zhang Ying Inventor before: Hou Guangzheng |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210831 |